1. Class III-A experiments

Class III-A experiments require IBC and Recombinant DNA Advisory Committee (RAC) review and NIH Director Approval before initiation. These experiments include:

  1. Deliberate transfer of a drug resistance trait to microorganisms that are not known to acquire the trait naturally, if such acquisition could compromise the use of the drug to control disease agents in human or veterinary medicine or agriculture.